A Bench Comparison of the Effect of High-Flow Oxygen Devices on Work of Breathing.


Journal

Respiratory care
ISSN: 1943-3654
Titre abrégé: Respir Care
Pays: United States
ID NLM: 7510357

Informations de publication

Date de publication:
09 2022
Historique:
pubmed: 6 7 2022
medline: 27 8 2022
entrez: 5 7 2022
Statut: ppublish

Résumé

Oxygen therapy via high-flow nasal cannula (HFNC) has been extensively used during the COVID-19 pandemic. The number of devices has also increased. We conducted this study to answer the following questions: Do HFNC devices differ from the original device for work of breathing (WOB) and generated PEEP? Seven devices were tested on ASL 5000 lung model. Compliance was set to 40 mL/cm H Baseline WOB and PEEP were comparable between devices. Over all the conditions tested, WOB was 4.2 (1.0-9.4) J/min with the reference device, and the relative variations from it were 0, -3 (2-4), 1 (0-1), -2 (1-2), -1 (1-2), and -1 (1-2)% with Airvo 2, G5, HM80, T60, V500, and V60 Plus devices, respectively, ( WOB was marginally higher and PEEP marginally lower with devices as compared to the reference device.

Sections du résumé

BACKGROUND
Oxygen therapy via high-flow nasal cannula (HFNC) has been extensively used during the COVID-19 pandemic. The number of devices has also increased. We conducted this study to answer the following questions: Do HFNC devices differ from the original device for work of breathing (WOB) and generated PEEP?
METHODS
Seven devices were tested on ASL 5000 lung model. Compliance was set to 40 mL/cm H
RESULTS
Baseline WOB and PEEP were comparable between devices. Over all the conditions tested, WOB was 4.2 (1.0-9.4) J/min with the reference device, and the relative variations from it were 0, -3 (2-4), 1 (0-1), -2 (1-2), -1 (1-2), and -1 (1-2)% with Airvo 2, G5, HM80, T60, V500, and V60 Plus devices, respectively, (
CONCLUSIONS
WOB was marginally higher and PEEP marginally lower with devices as compared to the reference device.

Identifiants

pubmed: 35790397
pii: respcare.09889
doi: 10.4187/respcare.09889
doi:

Substances chimiques

Oxygen S88TT14065

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1129-1137

Informations de copyright

Copyright © 2022 by Daedalus Enterprises.

Déclaration de conflit d'intérêts

The authors have disclosed no conflicts of interest.

Auteurs

Claude Guérin (C)

Medicine Intensive-Réanimation Hôpital Edouard Herriot, Lyon, France; Université de Lyon, Lyon, France; and Institut Mondor de Recherches Biomédicales, INSERM 955, CNRS ERL 7000, Créteil, France. claude.guerin@chu-lyon.fr.

Martin Cour (M)

Medicine Intensive-Réanimation Hôpital Edouard Herriot, Lyon, France; and Université de Lyon, Lyon, France.

Florian Degivry (F)

Medicine Intensive-Réanimation Hôpital Edouard Herriot, Lyon, France.

Laurent Argaud (L)

Medicine Intensive-Réanimation Hôpital Edouard Herriot, Lyon, France; and Université de Lyon, Lyon, France.

Bruno Louis (B)

Institut Mondor de Recherches Biomédicales, INSERM 955, CNRS ERL 7000, Créteil, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH